Skip to main content
رجوع
Watch Compare

Oncology Institute, Inc.

جودة البيانات: 100%
مُدرج أيضًا باسم DFPH Nasdaq TOIIW Nasdaq
TOI
Nasdaq Services Health Services
KWD 3.08
▼ KWD 0.03 (-0.96%)
القيمة السوقية: 303.44 M
السعر
KWD 3.07
القيمة السوقية
303.44 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Revenue grew 25.45% annually over 5 years — strong growth
Negative free cash flow of -27.79 M
Capital efficient — spends only 0.64% of revenue on capex

النمو

Revenue Growth (5Y)
25.45%
أعلى من متوسط القطاع (3.76%)
Revenue (1Y)27.79%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROIC-29.53%
Net Margin-12.06%
Op. Margin-7.18%

الأمان

Debt / Equity
N/A
Current Ratio1.68
Interest Coverage-3.20

التقييم

PE (TTM)
-5.01
أقل من متوسط القطاع (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Services (502 نظير)
المقياس السهم وسيط القطاع
P/E -5.0 -1.2
P/B — 1.4
ROE % — -16.0
Net Margin % -12.1 -19.4
Rev Growth 5Y % 25.5 3.8
D/E — 0.4

ETFs Holding This Stock

GISMX GISMX
0.04% weight
GMSMX GMSMX
0.04% weight
GSMRX GSMRX
0.04% weight
IRSIX IRSIX
0.01% weight
IIRSX IIRSX
0.01% weight
IRCIX IRCIX
0.01% weight
VVICX VVICX
0.01% weight
IRSSX IRSSX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 27.79% Revenue Growth (3Y) 24.52%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 25.45% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 502.73 M Net Income (TTM) -60.61 M
ROE N/A ROA -37.48%
Gross Margin N/A Operating Margin -7.18%
Net Margin -12.06% Free Cash Flow (TTM) -27.79 M
ROIC -29.53% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.68
Interest Coverage -3.20 Asset Turnover 3.11
Working Capital 44.51 M Tangible Book Value -31.24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.01 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.60
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9.16%
Market Cap 303.44 M Enterprise Value 379.63 M
Per Share
EPS (Diluted TTM) -0.54 Revenue / Share 5.09
FCF / Share -0.28 OCF / Share -0.25
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.64% FCF Conversion 45.85%
SBC-Adj. FCF -33.41 M Growth Momentum 2.34

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 502.73 M 393.41 M 324.24 M 252.48 M 203.00 M
Net Income -60.61 M -64.66 M -83.07 M 152,000.0 -10.93 M
EPS (Diluted) -0.54 -0.71 -0.92 -0.21 -0.16
Gross Profit — — — — —
Operating Income -36.08 M -60.12 M -77.02 M -81.95 M -45.86 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses 105.57 M 107.83 M 113.85 M 119.69 M 83.37 M
D&A 6.94 M 6.29 M 5.87 M 4.41 M 3.34 M
Interest Expense 11.28 M 7.50 M -6.78 M -4.08 M 320,000.0
Income Tax -131,000.0 0.0 -36,000.0 -243,000.0 -671,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 164.66 M 172.72 M 209.24 M 261.67 M 203.44 M
Total Liabilities 180.38 M 169.13 M 152.22 M 138.49 M 99.28 M
Shareholders' Equity -15.72 M 3.59 M 57.03 M 123.18 M 104.16 M
Total Debt 77.40 M 93.13 M 86.83 M 80.62 M 0.0
Cash & Equivalents — — — — —
Current Assets 112.75 M 112.42 M 143.49 M 130.42 M 154.06 M
Current Liabilities 70.96 M 52.22 M 34.79 M 29.72 M 29.80 M